Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12198575 [patent_doc_number] => 09901623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'Rapid-acting insulin compositions' [patent_app_type] => utility [patent_app_number] => 15/241412 [patent_app_country] => US [patent_app_date] => 2016-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17298 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241412 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/241412
Rapid-acting insulin compositions Aug 18, 2016 Issued
Array ( [id] => 11668476 [patent_doc_number] => 20170157196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/239708 [patent_app_country] => US [patent_app_date] => 2016-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7585 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15239708 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/239708
Peptide fragments for inducing synthesis of extracellular matrix proteins Aug 16, 2016 Issued
Array ( [id] => 11289119 [patent_doc_number] => 20160339050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events' [patent_app_type] => utility [patent_app_number] => 15/225886 [patent_app_country] => US [patent_app_date] => 2016-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15225886 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/225886
Methods of treating, reducing the incidence of, and/or preventing ischemic events Aug 1, 2016 Issued
Array ( [id] => 13026449 [patent_doc_number] => 10035840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => Targeted coagulation factors and method of using the same [patent_app_type] => utility [patent_app_number] => 15/222001 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7914 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222001 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/222001
Targeted coagulation factors and method of using the same Jul 27, 2016 Issued
Array ( [id] => 13793325 [patent_doc_number] => 20190010201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => Polypeptide for Inhibition of Tumor [patent_app_type] => utility [patent_app_number] => 15/746978 [patent_app_country] => US [patent_app_date] => 2016-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746978 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/746978
Polypeptide for inhibition of tumor Jul 20, 2016 Issued
Array ( [id] => 11362862 [patent_doc_number] => 20170000844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'Treatment of Ascites' [patent_app_type] => utility [patent_app_number] => 15/198050 [patent_app_country] => US [patent_app_date] => 2016-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3118 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15198050 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/198050
Treatment of ascites Jun 29, 2016 Issued
Array ( [id] => 12904714 [patent_doc_number] => 20180193413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => MAMMALIAN GLUCOSIDASE INHIBITORS, METHODS FOR THEIR USE AND PHARMACEUTICAL COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 15/740494 [patent_app_country] => US [patent_app_date] => 2016-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740494 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/740494
Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof Jun 28, 2016 Issued
Array ( [id] => 13675211 [patent_doc_number] => 20160376339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => DECOY PEPTIDES INHIBITING BINDING OF AMIGO2 AND 3-PHOSPHOINOSITIDE-DEPENDENT KINASE 1 [patent_app_type] => utility [patent_app_number] => 15/195844 [patent_app_country] => US [patent_app_date] => 2016-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15195844 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/195844
Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1 Jun 27, 2016 Issued
Array ( [id] => 12884986 [patent_doc_number] => 20180186837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES [patent_app_type] => utility [patent_app_number] => 15/738730 [patent_app_country] => US [patent_app_date] => 2016-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51261 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -115 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738730 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/738730
Broad-spectrum anti-infective peptides Jun 23, 2016 Issued
Array ( [id] => 11457167 [patent_doc_number] => 20170051072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'MODIFIED PSEUDOMONAS EXOTOXIN A' [patent_app_type] => utility [patent_app_number] => 15/191392 [patent_app_country] => US [patent_app_date] => 2016-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 56953 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191392 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/191392
MODIFIED PSEUDOMONAS EXOTOXIN A Jun 22, 2016 Abandoned
Array ( [id] => 13781019 [patent_doc_number] => 20190004048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor [patent_app_type] => utility [patent_app_number] => 15/737850 [patent_app_country] => US [patent_app_date] => 2016-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737850 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/737850
Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor Jun 21, 2016 Abandoned
Array ( [id] => 11541704 [patent_doc_number] => 20170095529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'ENDOMUCIN AS AN ANTI-INFLAMMATORY AGENT' [patent_app_type] => utility [patent_app_number] => 15/178837 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8580 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15178837 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/178837
ENDOMUCIN AS AN ANTI-INFLAMMATORY AGENT Jun 9, 2016 Abandoned
Array ( [id] => 13220633 [patent_doc_number] => 10124077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-13 [patent_title] => Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma [patent_app_type] => utility [patent_app_number] => 15/176920 [patent_app_country] => US [patent_app_date] => 2016-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 33 [patent_no_of_words] => 26601 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15176920 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/176920
Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma Jun 7, 2016 Issued
Array ( [id] => 15355557 [patent_doc_number] => 10526379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Methods and products for fusion protein synthesis [patent_app_type] => utility [patent_app_number] => 15/578486 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28445 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 467 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578486 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/578486
Methods and products for fusion protein synthesis Jun 2, 2016 Issued
Array ( [id] => 13182565 [patent_doc_number] => 10106786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Compositions and methods for modulating hemostasis [patent_app_type] => utility [patent_app_number] => 15/172904 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9251 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172904 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/172904
Compositions and methods for modulating hemostasis Jun 2, 2016 Issued
Array ( [id] => 11114889 [patent_doc_number] => 20160311858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'PEPTIDE-COMPOUND CYCLIZATION METHOD' [patent_app_type] => utility [patent_app_number] => 15/166550 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 222758 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166550 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/166550
PEPTIDE-COMPOUND CYCLIZATION METHOD May 26, 2016 Abandoned
Array ( [id] => 11491483 [patent_doc_number] => 20170065668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'PAR-1 Activation by Metalloproteinase-1 (MMP-1)' [patent_app_type] => utility [patent_app_number] => 15/165988 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33669 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165988 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/165988
PAR-1 Activation by Metalloproteinase-1 (MMP-1) May 25, 2016 Abandoned
Array ( [id] => 12791155 [patent_doc_number] => 20180155554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => Conotoxin Peptides for Use in Biofouling Deterrence [patent_app_type] => utility [patent_app_number] => 15/576522 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576522 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/576522
Conotoxin peptides for use in biofouling deterrence May 18, 2016 Issued
Array ( [id] => 14665039 [patent_doc_number] => 10370410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Cancer cell-targeting peptide and use thereof [patent_app_type] => utility [patent_app_number] => 15/575390 [patent_app_country] => US [patent_app_date] => 2016-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8926 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575390 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/575390
Cancer cell-targeting peptide and use thereof May 17, 2016 Issued
Array ( [id] => 15068559 [patent_doc_number] => 10463745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Materials for tissue regeneration [patent_app_type] => utility [patent_app_number] => 15/573166 [patent_app_country] => US [patent_app_date] => 2016-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 6 [patent_no_of_words] => 15139 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573166 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/573166
Materials for tissue regeneration May 11, 2016 Issued
Menu